HDAC9 and non-small cell lung carcinoma: These findings indicated that HDAC expression is significantly positively correlated with drug resistance in tumor cells, and its expression level and activity are significantly increased in drug-resistant cells and negatively correlated with the prognosis of NSCLC patients [41].